Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > Bids all gone / Going back to .05
View:
Post by oldtrouf on Jan 04, 2024 9:56am

Bids all gone / Going back to .05

BMO tried to pump this shell with a bit of volume but to no vail.  Months of stagnation lie ahead as VM struggles to keep the lights on.   Fluffy irrelevant news is all they got imo.  At least the SmoothieX taste good.
Comment by postie1 on Jan 04, 2024 1:07pm
Anybody know who made these posts? Nostradamus they ain't. ".04 on the bid.  Is this company still solvent?  Will it be delisted soon?" this next comment was on RC announcement " By the end of the year it will be long forgotten and VM will either no longer exist or partner up with some other company with ground breaking tech.   This has been going on for ...more  
Comment by whitenorth72 on Jan 04, 2024 1:20pm
That's why it's called a bulls#€t board. There's an ignore button available unless you want the comedy.
Comment by Spidersilk on Jan 04, 2024 1:22pm
I believe it was oldtrouf. cheers
Comment by CheckingReality on Jan 05, 2024 12:15am
Yah. That's right - the glass half empty guy. Always negative.
Comment by BoracayGuy on Jan 10, 2024 1:44pm
By the end of the year?  There 's products in 30 day stabilization now, with buyers waiting?  This association with RC will likely get VM (full) project financing by year end., IMO.   There's too much going on to argue with you... Call the company get on the narritive 2024 is VM's year.  Sales commencing ... I wouldn't bail no -  read the last three ...more  
Comment by postie1 on Jan 10, 2024 3:52pm
That 30 day stabilization is nice to know (made my day).  These guys are doing what they do which is moving the business plans along and not spending a ton of time pumping. I would love to know if any in the RC circle have been buying VM. but that is probably something we will never know. Thank you BorcayGuy
Comment by WarrantOfficer on Jan 10, 2024 6:18pm
BoracayGuy: where did you get your info on the products in 30 day stabilization with buyers waiting?
Comment by postie1 on Jan 11, 2024 8:18am
In case BorcayGuy does not answer, here is some food for thought I believe the Sept. 14 news release mentions the buyers and that they wanted a full slate of products for a seamless transtition. Plus from that news release we should be in the right time frame?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1